| Product Name | MF | CAS | Details |
|---|
| IFNG antibody (HRP) | Details |
| 17'-Estradiol dimethyl ether | C20H28O2 | 4954-14-7 | Details |
| 4,5-Dehydro-L-leucine | C6H11NO2 | 87392-13-0 | Details |
| 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline | C11H15N | 20364-31-2 | Details |
| Kushenol M | C30H36O7 | 101236-51-5 | Details |
| 7-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine | C11H14ClN | 616201-89-9 | Details |
| 3-Methoxy-2,5-dimethylaniline | C9H13NO | 102440-04-0 | Details |
| 5-(Aminomethyl)-2-thiouridine | C10H15N3O5S | 109666-14-0 | Details |
| Human GMCSF ELISA kit | Details |
| PARD6A Blocking Peptide | Details |
| 2,4-Dichloro-N-methylbenzylamine | C8H9Cl2N | 5013-77-4 | Details |
| cis-Norbornene-exo-2,3-dicarboxylic anhydride | C9H8O3 | 2746-19-2 | Details |
| 4-Chloro-1,3-thiazole-2-sulfonamide | C3H3ClN2O2S2 | 89501-94-0 | Details |
| Bis(1,3-dichloro-2-propyl) phosphate | C6H11Cl4O4P | 72236-72-7 | Details |
| Caspase 8 antibody (Ser347) | Details |
| 4,6-Dichloroquinoline | C9H5Cl2N | 4203-18-3 | Details |
| Rauvotetraphylline A | C20H26N2O3 | 1422506-49-7 | Details |
| Tert-Butyl 3-(Hydroxymethyl)-1-Methyl-6,7-Dihydro-1H-Pyrazolo[4,3-C]Pyridine-5(4H)-Carboxylate | C13H21N3O3 | 1330765-07-5 | Details |
| Ethyl 2-hydroxy-2-(4-methanesulfonylphenyl)propanoate | C12H16O5S | 1275811-23-8 | Details |
| [2-(5-Bromo-1H-imidazol-4-yl)ethyl]amine dihydrochloride | C5H10BrCl2N3 | 2172251-28-2 | Details |
| N-(5-Chloro-2-hydroxyphenyl)-3-(1-piperidinylsulfonyl)benzamide | C18H19ClN2O4S | 823837-22-5 | Details |
| 1-(5-Chloro-2-nitrobenzoyl)pyrrolidine | C11H11ClN2O3 | 541542-37-4 | Details |
| 2-(Phenoxymethyl)-1,3-thiazole-5-carboxylic acid | C11H9NO3S | 1017669-06-5 | Details |
| H-NPKSTRAFSNDDYVLNPTTG-OH | Details |
| N,N-Dimethylcyclohexanecarboxamide | C9H17NO | 17566-51-7 | Details |
| 1-Benzyl-3-methylamino-pyrrolidine | C12H18N2 | 96568-35-3 | Details |
| 2-{[(2-Aminopyridin-4-yl)methyl]sulfanyl}ethan-1-ol | C8H12N2OS | 1249351-05-0 | Details |
| (6-Chloro-4-methylpyridin-2-yl)methanamine | C7H9ClN2 | 1256806-98-0 | Details |
| 3-(1H-1,3-Benzodiazol-2-yl)-2,2-dimethylpropanoic acid | C12H14N2O2 | 95242-09-4 | Details |
| Potassium 3-[3-(dimethylamino)-1,2,4-oxadiazol-5-yl]propanoate | C7H12KN3O3 | 1796955-15-1 | Details |
| Methyl 4-(2-chloroacetyl)-3,4-dihydro-2H-1,4-benzoxazine-2-carboxylate | C12H12ClNO4 | 949980-36-3 | Details |
| KDAMP | Details |
| TER119 antibody (PE) | Details |
| H-LLFER-OH | Details |
| H-LVVVGAGGVGK-OH | Details |
| 5'-O-p-Anisoyl-N4-benzoyl-3'-fluoro-2',3'-dideoxycytidine | C24H22FN3O6 | Details |
| Methyl 2-chloro-5-fluoro-pyrimidine-4-carboxylate | C6H4ClFN2O2 | 1404364-32-4 | Details |
| 2',5'-Dichloroacetophenone | C8H6Cl2O | 2476-37-1 | Details |
| mGluR2/3 antibody | Details |
| PIM2 antibody | Details |
| 2-[(3-Methylcyclohexyl)oxy]butanoic acid | C11H20O3 | 1218052-49-3 | Details |
| 4-(2,4-Difluorophenoxy)piperidine hydrochloride | C11H14ClF2NO | 1171775-66-8 | Details |
| 2-ethoxypyridin-3-amine | C7H10N2O | 51468-01-0 | Details |
| 4-(2-Ethoxyethoxy)piperidine | C9H19NO2 | 70978-93-7 | Details |
| Ethyl 2-(4-(4-(trifluoromethyl)phenylamino)-3,5-thiazolyl)acetate | C14H13F3N2O2S | 918793-30-3 | Details |
| N-(2,5-Difluorophenyl)-2-chloropropanamide | C9H8ClF2NO | 923215-48-9 | Details |
| 8-Amino-1-tetralone hydrochloride | C10H11NO | 210346-49-9 | Details |
| SPATA5 antibody | Details |
| 4-(2,6-Difluorophenyl)-1,2,3,6-tetrahydropyridine | C11H11F2N | 869189-96-8 | Details |
| Influenza Virus A/Aichi/2/68 Haemagglutinin HA1 (195-209), X-31 | Details |
| Lycoctonine | C25H41NO7 | 26000-17-9 | Details |
| Uridine-3',5'-cyclic monophosphate sodium salt | C9H10N2NaO8P | 56632-58-7 | Details |
| UBE2G1 protein (His tag) | Details |
| 2-{5H,6H,7H,8H-[1,2,4]Triazolo[4,3-a]pyrazin-3-yl}pyridine | C10H11N5 | 1159522-34-5 | Details |
| Jatrorrhizine iodide | C20H20INO4 | 1168-00-9 | Details |
| Oxan-4-yl[3-(trifluoromethyl)phenyl]methanamine hydrochloride | C13H17ClF3NO | 1803591-16-3 | Details |
| 5-(4-Bromophenyl)-1,3,4-oxadiazol-2-amine | C8H6BrN3O | 33621-62-4 | Details |
| Macrocarpal A | C28H40O6 | 132951-90-7 | Details |
| 3-(3-Bromopyridin-4-yl)propan-1-ol | C8H10BrNO | 229184-01-4 | Details |
| Lenacil | C13H18N2O2 | 2164-08-1 | Details |
| 1-Adamantanemethylamine, N,-dimethyl-, hydrochloride (8CI) | C13H24ClN | 33191-51-4 | Details |
| 6-Fluoro-3-hydroxy-2-methylpyridine | C6H6FNO | 1227577-28-7 | Details |
| Chloramphenicol 1-O-β-D-galactopyranoside | C17H22Cl2N2O10 | 191476-32-1 | Details |
| Benzyl(dodecan-2-yl)amine | C19H33N | 1427378-88-8 | Details |
| 3-Amino-N,N-dimethyl-2-phenylpropanamide hydrochloride | C11H17ClN2O | 2060005-04-9 | Details |
| 4',2-Dihydroxy-3-methoxychalcone | C16H14O4 | 206194-33-4 | Details |
| 2-{[(tert-Butoxy)carbonyl]amino}-4,4-difluoropentanoic acid | C10H17F2NO4 | 1822586-02-6 | Details |
| 1-(3-Fluoro-5-methoxyphenyl)-1H-pyrazole-3-carboxylic acid | C11H9FN2O3 | 2024389-76-0 | Details |
| 1-[4-(Methylsulfonyl)-2-nitrophenyl]piperazine | C11H15N3O4S | 610275-77-9 | Details |
| SEMA3D Blocking Peptide | Details |
| 3-(3,6-Dichloro-9H-carbazol-9-yl)propanoic acid | C15H11Cl2NO2 | 300816-42-6 | Details |
| Vaginidin | C19H22O6 | 31456-93-6 | Details |
| GSK 2830371-d4 | C23H29ClN4O2S | 1404456-53-6 | Details |
| 4-(Oxetan-3-yloxy)aniline | C9H11NO2 | 1349715-80-5 | Details |
| 4-Methylsulphonylaniline | C7H9NO2S | 5470-49-5 | Details |
| 5-(Aminomethyl)-2,3-dihydro-1H-pyrazol-3-one dihydrochloride | C4H8ClN3O | 27377-56-6 | Details |
| 3-(1-Methyl-1H-pyrazol-4-yl)piperidine | C9H15N3 | 1340528-88-2 | Details |
| 1H-Imidazol-2-yl(pyridin-4-yl)methanol | C9H9N3O | 1537797-18-4 | Details |
| 4-Methoxy-3-methylphenylacetone | C11H14O2 | 16882-23-8 | Details |
| 4-Chloro-2-methylquinoline-8-sulfonamide | C10H9ClN2O2S | 1121527-72-7 | Details |
| 2-Acetamido-3-O-benzoyl-4,6-O-benzylidene-2-deoxy-D-glucopyranose | C22H23NO7 | 1486465-81-9 | Details |
| 2-Methoxy-1-[(4-methylphenyl)sulphinyl]benzene | C14H14O2S | 320576-23-6 | Details |
| 25-Hydroxy vitamin d3 3-sulfate sodium salt | C27H44O5S | 99447-30-0 | Details |
| ZNF597 Blocking Peptide | Details |
| 2-Methoxystypandrone | C14H12O5 | 85122-21-0 | Details |
| 5-(Trifluoromethyl)pyridine-2-sulfonamide | C6H5F3N2O2S | 332366-24-2 | Details |
| 5-Bromo-4-methyl-thiazol-2-ylamine hydrobromide | C4H6Br2N2S | 79247-77-1 | Details |
| 2-Amino-1-(4-methoxy-3-nitrophenyl)ethanone hydrochloride | C9H11ClN2O4 | 877395-19-2 | Details |
| 2,6-di-O-n-pentyl-3-O-trifluroacetyl-gamma-cyclodextrin | Details |
| ACSL6 antibody | Details |
| Methyl({6-methylimidazo[2,1-b][1,3]thiazol-5-yl}methyl)amine dihydrochloride | C8H12ClN3S | 1258650-30-4 | Details |
| CTF1 antibody | Details |
| 2-Cyclopropyl-1-nitro-naphthalene | C13H11NO2 | 52331-35-8 | Details |
| 5-(Tetrahydrofuran-3-yl)thiazol-2-amine | C7H10N2OS | 1565386-73-3 | Details |
| 3-Chloro-4-hydroxy-5-methoxybenzonitrile | C8H6ClNO2 | 5485-88-1 | Details |
| Schizandriside | C25H32O10 | 71222-06-5 | Details |
| 2-Bromo-5-(2-nitroprop-1-en-1-yl)furan | C7H6BrNO3 | 35950-37-9 | Details |
| Bovine IgG (Fc) | Details |
| 6-(1,5-Dimethyl-1H-pyrazol-4-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid | C13H13N5O2 | 1855890-07-1 | Details |
| H-NANAEPAVQR-OH | Details |
| Product Total： Product Page： | ||||
| 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 | ||||